Pharma-Bio Serv (PBSV) EBITDA Margin Growth (1y) (2011 - 2026)
Pharma-Bio Serv (PBSV) EBITDA Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | -596.00 |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 160.00 |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 1,273.00 |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 529.00 |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 1,409.00 |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | -1,812.00 |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 37.00 |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 12.00 |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 975.00 |
| 10 | Pharma-Bio Serv | - | - | 902,041.00 | 942.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 942.00 |
| Jan 31, 2026 | -39.00 |
| Oct 31, 2025 | 41.00 |
| Jul 31, 2025 | -20.00 |
| Apr 30, 2025 | 911.00 |
| Jan 31, 2025 | 1,468.00 |
| Oct 31, 2024 | -517.00 |
| Jul 31, 2024 | -2,585.00 |
| Apr 30, 2024 | -2,151.00 |
| Jan 31, 2024 | -2,617.00 |
| Oct 31, 2023 | -508.00 |
| Jul 31, 2023 | 232.00 |
| Apr 30, 2023 | 268.00 |
| Jan 31, 2023 | 66.00 |
| Oct 31, 2022 | 8,936.00 |
| Jul 31, 2022 | 51.00 |
| Apr 30, 2022 | 40.00 |
| Jan 31, 2022 | -2.00 |
| Oct 31, 2021 | -8,874.00 |
| Jul 31, 2021 | -578.00 |